PRME
PRME

Prime Medicine Inc

NASDAQ · Biotechnology
$3.57
+0.33 (+10.19%)
Analyst Consensus
Buy
17 analysts
Buy 12 71%
Hold 5 29%
Sell 0 0%
Price Target
Analyst Price Target +1,109.8% upside
Low Target $33.60
Average Target $43.19
High Target $71.66
Current Price $3.57
Current
$3.57
Target
$43.19
$33.60 $43.19 avg $71.66